Perceptual distortions and delusional thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe

Journal of Psychopharmacology

Volumn 29, Issue 9, 2015, Pages 1025-1028

  Stone, James ^a   Kotoula, Vasileia ^a   Dietrich, Craige ^a   De Simoni, Sara ^a   Krystal, John H ^b,c,d,e   Mehta, Mitul A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

^d Clinical Neuroscience Division VA National Center for PTSD   (United States)

^e VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

BOLD; fMRI; Ketamine; psychosis

Indexed keywords

KETAMINE; ANESTHETIC AGENT; OXYGEN;

ADULT; ARTICLE; BOLD SIGNAL; BRAIN CORTEX; BRAIN FUNCTION; CINGULATE GYRUS; CONNECTOME; CONTROLLED STUDY; DELUSION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; INSULA; MALE; MESENCEPHALON; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PARIETAL LOBE; PERCEPTION DISORDER; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOTOMIMETIC STATES INVENTORY; SELF CONCEPT; SUBCORTEX; SUPERIOR PARIETAL LOBULE; THALAMUS; ADOLESCENT; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; PSYCHOSIS; SCHIZOPHRENIA; YOUNG ADULT;

ADOLESCENT; ADULT; ANESTHETICS, DISSOCIATIVE; DELUSIONS; HUMANS; KETAMINE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; PARIETAL LOBE; PERCEPTUAL DISTORTION; PSYCHOSES, SUBSTANCE-INDUCED; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84942109339     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881115592337     Document Type: Article

References (18)

1. Absalom AR, Lee M, Menon DK, et al. (2007) Predictive performance of the Domino, Hijazi, and Clements models during low-dose target-controlled ketamine infusions in healthy volunteers. Br J Anaesth 98: 615-623.
2. Anticevic A, Gancsos M, Murray JD, et al. (2012) NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proc Natl Acad Sci U S A 109: 16720-16725.
3. Blakemore SJ, Oakley DA, Frith CD, (2003) Delusions of alien control in the normal brain. Neuropsychologia 41: 1058-1067.
4. Clements JA, Nimmo WS, (1981) Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 53: 27-30.
5. De Simoni S, Schwarz AJ, ODaly OG, et al. (2012) Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers. Neuroimage 64C: 75-90.
6. Deakin JF, Lees J, McKie S, et al. (2008) Glutamate and the neural basis of the subjective effects of ketamine: A pharmaco-magnetic resonance imaging study. Arch Gen Psychiatry 65: 154-164.
7. Doyle OM, De Simoni S, Schwarz AJ, et al. (2013) Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: A validation using antipsychotic and glutamatergic agents. J Pharmacol Exp Ther 345: 151-160.
8. Driesen NR, McCarthy G, Bhagwagar Z, et al. (2013) Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Mol Psychiatry 18: 1199-1204.
9. Duncan GE, Moy SS, Knapp DJ, et al. (1998) Metabolic mapping of the rat brain after subanesthetic doses of ketamine: Potential relevance to schizophrenia. Brain Res 787: 181-190.
10. Frith C, (2005) The self in action: Lessons from delusions of control. Conscious Cogn 14: 752-770.
11. Krystal JH, Perry EBJ, Gueorguieva R, et al. (2005) Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: Implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62: 985-994.
12. Langsjo JW, Salmi E, Kaisti KK, et al. (2004) Effects of subanesthetic ketamine on regional cerebral glucose metabolism in humans. Anesthesiology 100: 1065-1071.
13. Littlewood CL, Jones N, ONeill MJ, et al. (2006) Mapping the central effects of ketamine in the rat using pharmacological MRI. Psychopharmacology (Berl) 186: 64-81.
14. Mason OJ, Morgan CJ, Stefanovic A, et al. (2008) The psychotomimetic states inventory (PSI): Measuring psychotic-type experiences from ketamine and cannabis. Schizophr Res 103: 138-142.
15. Niesters M, Khalili-Mahani N, Martini C, et al. (2012) Effect of subanesthetic ketamine on intrinsic functional brain connectivity: A placebo-controlled functional magnetic resonance imaging study in healthy male volunteers. Anesthesiology 117: 868-877.
16. Penfield W, Rasmussen T, (1950) The cerebral cortex of man. New York: Macmillan.
17. Scheidegger M, Walter M, Lehmann M, et al. (2012) Ketamine decreases resting state functional network connectivity in healthy subjects: Implications for antidepressant drug action. PLoS One 7: e44799.
18. Stone JM, Dietrich C, Edden R, et al. (2012) Ketamine effects on brain GABA and glutamate levels with 1H-MRS: Relationship to ketamine-induced psychopathology. Mol Psychiatry 17: 664-665.